SCHEMBL8789969

SCHEMBL8789969

COc1ccc(CN(C)C/C=C/c2ccc(N)cc2)cc1OC

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.57
ACHE P22303 1/20 0.57
CYP19A1 P11511 2/20 0.55
KCNH2 Q12809 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8789973 1.00 BCHE (0.57) BCHEACHECYP19A1KCNH2
SCHEMBL8790071 0.87 CYP19A1 (0.54) BCHEACHECYP19A1
SCHEMBL8790080 0.87 CYP19A1 (0.54) BCHEACHECYP19A1
SCHEMBL8790222 0.82 PTGS2 (0.60) BCHEACHECYP19A1KCNH2
SCHEMBL8790218 0.82 PTGS2 (0.60) BCHEACHECYP19A1KCNH2
SCHEMBL3147612 0.82 CYP19A1 (0.65) BCHEACHECYP19A1
SCHEMBL8790306 0.79 CYP19A1 (0.61) BCHEACHECYP19A1
SCHEMBL8789804 0.77 CYP19A1 (0.67) CYP19A1
SCHEMBL15903365 0.75 CYP19A1 (0.69) CYP19A1
SCHEMBL8789870 0.75 CYP19A1 (0.63) CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569380-B1 ACRIDINE DERIVATIVES GLAXO LAB SA (FR) 1997-05-28 EP disclosed
US-5604237-A IMPROVE OR INCREASE EFFICACY OF ANTITUMOR AGENT, INCREASE OR RESTORE SENSITIVITY OF TUMOR TO ANTITUMOR AGENT, REVERSE OR REDUCE RESISTANCE OF TUMOR TO ANTITUMOR AGENT LABORATOIRES GLAXO SA (FR) 1997-02-18 US disclosed